位置:首页 > 蛋白库 > CBPC5_MOUSE
CBPC5_MOUSE
ID   CBPC5_MOUSE             Reviewed;         886 AA.
AC   Q09M02; D3Z6S8; Q09M01; Q09M03; Q09M04; Q6PFZ3; Q8BLL9; Q8BM52; Q8BZD8;
AC   Q8C0W4;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 2.
DT   03-AUG-2022, entry version 110.
DE   RecName: Full=Cytosolic carboxypeptidase-like protein 5 {ECO:0000303|PubMed:21074048};
DE            EC=3.4.17.- {ECO:0000269|PubMed:20519502, ECO:0000269|PubMed:21074048, ECO:0000269|PubMed:24022482, ECO:0000269|PubMed:26829768};
DE            EC=3.4.17.24 {ECO:0000269|PubMed:24022482, ECO:0000269|PubMed:26829768};
DE   AltName: Full=ATP/GTP-binding protein-like 5;
DE   AltName: Full=Protein deglutamylase CCP5 {ECO:0000305};
GN   Name=Agbl5 {ECO:0000312|MGI:MGI:2441745};
GN   Synonyms=Ccp5 {ECO:0000303|PubMed:21074048};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3; 4 AND 7), TISSUE SPECIFICITY,
RP   AND SUBCELLULAR LOCATION.
RC   STRAIN=C57BLKS/J;
RX   PubMed=17244818; DOI=10.1096/fj.06-7329com;
RA   Kalinina E., Biswas R., Berezniuk I., Hermoso A., Aviles F.X.,
RA   Fricker L.D.;
RT   "A novel subfamily of mouse cytosolic carboxypeptidases.";
RL   FASEB J. 21:836-850(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3; 5 AND 6).
RC   STRAIN=C57BL/6J;
RC   TISSUE=Brain cortex, Embryoid bodies, Testis, and Urinary bladder;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-841, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF HIS-252 AND GLU-255.
RX   PubMed=21074048; DOI=10.1016/j.cell.2010.10.014;
RA   Rogowski K., van Dijk J., Magiera M.M., Bosc C., Deloulme J.C., Bosson A.,
RA   Peris L., Gold N.D., Lacroix B., Grau M.B., Bec N., Larroque C.,
RA   Desagher S., Holzer M., Andrieux A., Moutin M.J., Janke C.;
RT   "A family of protein-deglutamylating enzymes associated with
RT   neurodegeneration.";
RL   Cell 143:564-578(2010).
RN   [7]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=20519502; DOI=10.1074/jbc.c110.128280;
RA   Kimura Y., Kurabe N., Ikegami K., Tsutsumi K., Konishi Y., Kaplan O.I.,
RA   Kunitomo H., Iino Y., Blacque O.E., Setou M.;
RT   "Identification of tubulin deglutamylase among Caenorhabditis elegans and
RT   mammalian cytosolic carboxypeptidases (CCPs).";
RL   J. Biol. Chem. 285:22936-22941(2010).
RN   [8]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=24022482; DOI=10.1074/jbc.m113.497917;
RA   Berezniuk I., Lyons P.J., Sironi J.J., Xiao H., Setou M., Angeletti R.H.,
RA   Ikegami K., Fricker L.D.;
RT   "Cytosolic carboxypeptidase 5 removes alpha- and gamma-linked glutamates
RT   from tubulin.";
RL   J. Biol. Chem. 288:30445-30453(2013).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=25103237; DOI=10.1091/mbc.e14-06-1072;
RA   Tort O., Tanco S., Rocha C., Bieche I., Seixas C., Bosc C., Andrieux A.,
RA   Moutin M.J., Aviles F.X., Lorenzo J., Janke C.;
RT   "The cytosolic carboxypeptidases CCP2 and CCP3 catalyze posttranslational
RT   removal of acidic amino acids.";
RL   Mol. Biol. Cell 25:3017-3027(2014).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF
RP   HIS-252 AND GLU-255.
RX   PubMed=26829768; DOI=10.1038/ni.3356;
RA   Xia P., Ye B., Wang S., Zhu X., Du Y., Xiong Z., Tian Y., Fan Z.;
RT   "Glutamylation of the DNA sensor cGAS regulates its binding and synthase
RT   activity in antiviral immunity.";
RL   Nat. Immunol. 17:369-378(2016).
CC   -!- FUNCTION: Metallocarboxypeptidase that mediates deglutamylation of
CC       tubulin and non-tubulin target proteins (PubMed:21074048,
CC       PubMed:20519502, PubMed:24022482, PubMed:26829768). Catalyzes the
CC       removal of polyglutamate side chains present on the gamma-carboxyl
CC       group of glutamate residues within the C-terminal tail of alpha- and
CC       beta-tubulin (PubMed:21074048, PubMed:20519502, PubMed:24022482).
CC       Cleaves alpha- and gamma-linked polyglutamate tubulin side-chain, as
CC       well as the branching point glutamate (PubMed:21074048,
CC       PubMed:24022482). Also catalyzes the removal of alpha-linked glutamate
CC       residues from the carboxy-terminus of alpha-tubulin (PubMed:24022482).
CC       Mediates deglutamylation of nucleotidyltransferase CGAS, leading to
CC       CGAS antiviral defense response activation (PubMed:26829768).
CC       {ECO:0000269|PubMed:20519502, ECO:0000269|PubMed:21074048,
CC       ECO:0000269|PubMed:24022482, ECO:0000269|PubMed:26829768}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=gamma-L-glutamyl-L-glutamyl-[protein] + H2O = L-glutamate + L-
CC         glutamyl-[protein]; Xref=Rhea:RHEA:60152, Rhea:RHEA-COMP:10208,
CC         Rhea:RHEA-COMP:15517, ChEBI:CHEBI:15377, ChEBI:CHEBI:29973,
CC         ChEBI:CHEBI:29985, ChEBI:CHEBI:143622;
CC         Evidence={ECO:0000269|PubMed:20519502, ECO:0000269|PubMed:21074048};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60153;
CC         Evidence={ECO:0000305|PubMed:20519502, ECO:0000305|PubMed:21074048};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(L-glutamyl)(n+1)-gamma-L-glutamyl-L-glutamyl-[protein] + H2O
CC         = (L-glutamyl)(n)-gamma-L-glutamyl-L-glutamyl-[protein] + L-
CC         glutamate; Xref=Rhea:RHEA:60004, Rhea:RHEA-COMP:15519, Rhea:RHEA-
CC         COMP:15675, ChEBI:CHEBI:15377, ChEBI:CHEBI:29985, ChEBI:CHEBI:143623;
CC         Evidence={ECO:0000269|PubMed:24022482, ECO:0000269|PubMed:26829768};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60005;
CC         Evidence={ECO:0000269|PubMed:26829768, ECO:0000305|PubMed:24022482};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=C-terminal L-alpha-aminoacyl-L-glutamyl-[tubulin] + H2O = C-
CC         terminal L-alpha-aminoacyl-[tubulin] + L-glutamate;
CC         Xref=Rhea:RHEA:63796, Rhea:RHEA-COMP:16436, Rhea:RHEA-COMP:16437,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:29985, ChEBI:CHEBI:90782,
CC         ChEBI:CHEBI:149556; EC=3.4.17.24;
CC         Evidence={ECO:0000269|PubMed:24022482};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63797;
CC         Evidence={ECO:0000305|PubMed:24022482};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=C-terminal L-alpha-aminoacyl-L-glutamyl-L-glutamyl-[tubulin] +
CC         H2O = C-terminal L-alpha-aminoacyl-L-glutamyl-[tubulin] + L-
CC         glutamate; Xref=Rhea:RHEA:63792, Rhea:RHEA-COMP:16435, Rhea:RHEA-
CC         COMP:16436, ChEBI:CHEBI:15377, ChEBI:CHEBI:29985, ChEBI:CHEBI:149555,
CC         ChEBI:CHEBI:149556; EC=3.4.17.24;
CC         Evidence={ECO:0000269|PubMed:24022482};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63793;
CC         Evidence={ECO:0000305|PubMed:24022482};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:P00730};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250|UniProtKB:P00730};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:17244818,
CC       ECO:0000269|PubMed:24022482}. Nucleus {ECO:0000269|PubMed:17244818}.
CC       Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:Q8NDL9}.
CC       Midbody {ECO:0000250|UniProtKB:Q8NDL9}. Note=Colocalizes with alpha-
CC       tubulin in the mitotic spindle and with midbody microtubules in the
CC       intercellular bridges formed during cytokinesis (By similarity). Mainly
CC       cytoplasmic. Slight accumulation in the nucleus is observed
CC       (PubMed:17244818). {ECO:0000250|UniProtKB:Q8NDL9,
CC       ECO:0000269|PubMed:17244818}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1;
CC         IsoId=Q09M02-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q09M02-2; Sequence=VSP_040433;
CC       Name=3;
CC         IsoId=Q09M02-3; Sequence=VSP_040432;
CC       Name=4;
CC         IsoId=Q09M02-4; Sequence=VSP_040434;
CC       Name=5;
CC         IsoId=Q09M02-5; Sequence=VSP_040427, VSP_040428, VSP_040429,
CC                                  VSP_040430;
CC       Name=6;
CC         IsoId=Q09M02-6; Sequence=VSP_040431;
CC       Name=7;
CC         IsoId=Q09M02-7; Sequence=VSP_040428, VSP_040433;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highly expressed in testis, and
CC       moderately in pituitary, brain, eye and kidney.
CC       {ECO:0000269|PubMed:17244818, ECO:0000269|PubMed:25103237}.
CC   -!- DISRUPTION PHENOTYPE: Mice are more vulnerable to DNA virus infection
CC       due to impaired immune response. {ECO:0000269|PubMed:26829768}.
CC   -!- SIMILARITY: Belongs to the peptidase M14 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH57349.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ867034; ABI51953.1; -; mRNA.
DR   EMBL; DQ867035; ABI51954.1; -; mRNA.
DR   EMBL; DQ867036; ABI51955.1; -; mRNA.
DR   EMBL; DQ867037; ABI51956.1; -; mRNA.
DR   EMBL; DQ867038; ABI51957.1; -; mRNA.
DR   EMBL; AK029676; BAC26559.1; -; mRNA.
DR   EMBL; AK035680; BAC29150.1; -; mRNA.
DR   EMBL; AK034894; BAC28871.1; -; mRNA.
DR   EMBL; AK044195; BAC31813.1; -; mRNA.
DR   EMBL; AC109606; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC057349; AAH57349.1; ALT_INIT; mRNA.
DR   CCDS; CCDS19165.1; -. [Q09M02-6]
DR   CCDS; CCDS39048.1; -. [Q09M02-7]
DR   CCDS; CCDS80242.1; -. [Q09M02-3]
DR   CCDS; CCDS89898.1; -. [Q09M02-2]
DR   RefSeq; NP_001041657.1; NM_001048192.2. [Q09M02-7]
DR   RefSeq; NP_001281191.1; NM_001294262.1. [Q09M02-3]
DR   RefSeq; NP_777274.1; NM_174849.3. [Q09M02-6]
DR   RefSeq; XP_006503936.1; XM_006503873.3. [Q09M02-2]
DR   RefSeq; XP_006503937.1; XM_006503874.3. [Q09M02-4]
DR   RefSeq; XP_006503938.1; XM_006503875.1. [Q09M02-1]
DR   RefSeq; XP_006503939.1; XM_006503876.1. [Q09M02-1]
DR   RefSeq; XP_006503940.1; XM_006503877.1. [Q09M02-1]
DR   AlphaFoldDB; Q09M02; -.
DR   SMR; Q09M02; -.
DR   STRING; 10090.ENSMUSP00000110348; -.
DR   MEROPS; M14.036; -.
DR   iPTMnet; Q09M02; -.
DR   PhosphoSitePlus; Q09M02; -.
DR   PaxDb; Q09M02; -.
DR   PRIDE; Q09M02; -.
DR   ProteomicsDB; 283697; -. [Q09M02-1]
DR   ProteomicsDB; 283698; -. [Q09M02-2]
DR   ProteomicsDB; 283699; -. [Q09M02-3]
DR   ProteomicsDB; 283700; -. [Q09M02-4]
DR   ProteomicsDB; 283701; -. [Q09M02-5]
DR   ProteomicsDB; 283702; -. [Q09M02-6]
DR   ProteomicsDB; 283703; -. [Q09M02-7]
DR   Antibodypedia; 28106; 156 antibodies from 25 providers.
DR   DNASU; 231093; -.
DR   Ensembl; ENSMUST00000069705; ENSMUSP00000063228; ENSMUSG00000029165. [Q09M02-6]
DR   Ensembl; ENSMUST00000114700; ENSMUSP00000110348; ENSMUSG00000029165. [Q09M02-7]
DR   Ensembl; ENSMUST00000201168; ENSMUSP00000143808; ENSMUSG00000029165. [Q09M02-1]
DR   Ensembl; ENSMUST00000201225; ENSMUSP00000143934; ENSMUSG00000029165. [Q09M02-3]
DR   Ensembl; ENSMUST00000201817; ENSMUSP00000144304; ENSMUSG00000029165. [Q09M02-4]
DR   Ensembl; ENSMUST00000201917; ENSMUSP00000144188; ENSMUSG00000029165. [Q09M02-2]
DR   Ensembl; ENSMUST00000202060; ENSMUSP00000144018; ENSMUSG00000029165. [Q09M02-3]
DR   GeneID; 231093; -.
DR   KEGG; mmu:231093; -.
DR   UCSC; uc008wwc.1; mouse. [Q09M02-6]
DR   UCSC; uc008wwd.1; mouse. [Q09M02-5]
DR   UCSC; uc008wwf.2; mouse. [Q09M02-3]
DR   UCSC; uc008wwg.2; mouse. [Q09M02-7]
DR   CTD; 60509; -.
DR   MGI; MGI:2441745; Agbl5.
DR   VEuPathDB; HostDB:ENSMUSG00000029165; -.
DR   eggNOG; KOG3641; Eukaryota.
DR   GeneTree; ENSGT00940000158032; -.
DR   HOGENOM; CLU_007523_3_2_1; -.
DR   InParanoid; Q09M02; -.
DR   OMA; NCAHFDF; -.
DR   PhylomeDB; Q09M02; -.
DR   TreeFam; TF324301; -.
DR   BRENDA; 3.4.17.24; 3474.
DR   BioGRID-ORCS; 231093; 2 hits in 72 CRISPR screens.
DR   ChiTaRS; Agbl5; mouse.
DR   PRO; PR:Q09M02; -.
DR   Proteomes; UP000000589; Chromosome 5.
DR   RNAct; Q09M02; protein.
DR   Bgee; ENSMUSG00000029165; Expressed in spermatid and 192 other tissues.
DR   ExpressionAtlas; Q09M02; baseline and differential.
DR   Genevisible; Q09M02; MM.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0045171; C:intercellular bridge; ISO:MGI.
DR   GO; GO:0015630; C:microtubule cytoskeleton; ISO:MGI.
DR   GO; GO:0030496; C:midbody; ISS:UniProtKB.
DR   GO; GO:0072686; C:mitotic spindle; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0004181; F:metallocarboxypeptidase activity; IDA:UniProtKB.
DR   GO; GO:0015631; F:tubulin binding; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0035609; P:C-terminal protein deglutamylation; IDA:UniProtKB.
DR   GO; GO:0051607; P:defense response to virus; IMP:UniProtKB.
DR   GO; GO:0035611; P:protein branching point deglutamylation; IDA:UniProtKB.
DR   GO; GO:0035608; P:protein deglutamylation; IDA:UniProtKB.
DR   GO; GO:0035610; P:protein side chain deglutamylation; IMP:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   CDD; cd06236; M14_AGBL5_like; 1.
DR   InterPro; IPR034286; M14_AGBL5-like.
DR   InterPro; IPR040626; Pepdidase_M14_N.
DR   InterPro; IPR000834; Peptidase_M14.
DR   Pfam; PF18027; Pepdidase_M14_N; 1.
DR   Pfam; PF00246; Peptidase_M14; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Carboxypeptidase; Cytoplasm; Cytoskeleton; Hydrolase;
KW   Metal-binding; Metalloprotease; Nucleus; Phosphoprotein; Protease;
KW   Reference proteome; Zinc.
FT   CHAIN           1..886
FT                   /note="Cytosolic carboxypeptidase-like protein 5"
FT                   /id="PRO_0000305922"
FT   REGION          344..363
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          374..401
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          602..737
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          783..846
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        618..670
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        692..709
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        711..737
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        799..821
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        829..843
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        303
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:P00730"
FT   BINDING         252
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000305|PubMed:21074048"
FT   BINDING         255
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000305|PubMed:21074048"
FT   BINDING         434
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P00730"
FT   MOD_RES         841
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   VAR_SEQ         1..92
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_040427"
FT   VAR_SEQ         129
FT                   /note="E -> ELGSKLSPCFSKPEEAGSHVESVRGRELVK (in isoform 5
FT                   and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:16141072,
FT                   ECO:0000303|PubMed:17244818"
FT                   /id="VSP_040428"
FT   VAR_SEQ         456..458
FT                   /note="VEN -> VGL (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_040429"
FT   VAR_SEQ         459..886
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_040430"
FT   VAR_SEQ         697..886
FT                   /note="EPRCSDRRRRQQPLNHRSTTSSLAPSPTLASSGPTSSRNMGSCLLPNSLSLS
FT                   GSSCSFSSSGDKPEAVMVIGKSLLGAGARIPCIRTRLQARPRLGRSSPPTRRGMRGSSP
FT                   TSPIPQTRESSELEPGPHSATPGLPQAGPPRPRSAPAFSPISCTLSDSPSRICYSRGLL
FT                   NQCEVCFVPKSPPLTISPRV -> GKPVWEPLQQVFGCLGHCWGERA (in isoform
FT                   6)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_040431"
FT   VAR_SEQ         750..886
FT                   /note="SSCSFSSSGDKPEAVMVIGKSLLGAGARIPCIRTRLQARPRLGRSSPPTRRG
FT                   MRGSSPTSPIPQTRESSELEPGPHSATPGLPQAGPPRPRSAPAFSPISCTLSDSPSRIC
FT                   YSRGLLNQCEVCFVPKSPPLTISPRV -> RYPLPLKPELPTFFPFLPPRA (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16141072,
FT                   ECO:0000303|PubMed:17244818"
FT                   /id="VSP_040432"
FT   VAR_SEQ         787..886
FT                   /note="ARPRLGRSSPPTRRGMRGSSPTSPIPQTRESSELEPGPHSATPGLPQAGPPR
FT                   PRSAPAFSPISCTLSDSPSRICYSRGLLNQCEVCFVPKSPPLTISPRV -> TCQRRVS
FT                   ARRGPGFPRLGPGWAGAHRRLAEG (in isoform 2 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:16141072,
FT                   ECO:0000303|PubMed:17244818"
FT                   /id="VSP_040433"
FT   VAR_SEQ         787..886
FT                   /note="ARPRLGRSSPPTRRGMRGSSPTSPIPQTRESSELEPGPHSATPGLPQAGPPR
FT                   PRSAPAFSPISCTLSDSPSRICYSRGLLNQCEVCFVPKSPPLTISPRV -> TPLSLPD
FT                   APQPQPTSFGFPTRP (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:17244818"
FT                   /id="VSP_040434"
FT   MUTAGEN         252
FT                   /note="H->S: Abolishes deglutamylase activity; when
FT                   associated with Q-255."
FT                   /evidence="ECO:0000269|PubMed:21074048,
FT                   ECO:0000269|PubMed:26829768"
FT   MUTAGEN         255
FT                   /note="E->Q: Abolishes deglutamylase activity; when
FT                   associated with S-252."
FT                   /evidence="ECO:0000269|PubMed:21074048,
FT                   ECO:0000269|PubMed:26829768"
FT   CONFLICT        103
FT                   /note="S -> A (in Ref. 2; BAC29150)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        337
FT                   /note="H -> R (in Ref. 2; BAC28871)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   886 AA;  97607 MW;  58A971BD521890D6 CRC64;
     MELRCGGLLF SSRFDSGNLA HVEKVETVSS DGEGVGGVAT APASGSAASP DYEFNVWTRP
     DCAETEYENG NRSWFYFSVR GGTPGKLIKI NIMNMNKQSK LYSQGMAPFV RTLPSRPRWE
     RIRERPTFEM TETQFVLSFV HRFVEGRGAT TFFAFCYPFS YSDCQDLLSQ LDQRFSENYS
     THSSPLDSIY YHRELLCYSL DGLRVDLLTI TSCHGLRDDR EPRLEQLFPD LGTPRPFRFT
     GKRIFFLSSR VHPGETPSSF VFNGFLDFIL RPDDPRAQTL RRLFVFKLIP MLNPDGVVRG
     HYRTDSRGVN LNRQYLKPDA VLHPAIYGAK AVLLYHHVHS RLNAKSPTNQ QPTLHLPPEA
     PLSDLEKANN LHNEAHLGQS PDGENPATWP ETEPAEEKTD PVWLMPQPIP ELEEPAPDTI
     PPKESGVAYY VDLHGHASKR GCFMYGNSFS DESTQVENML YPKLISLNSA HFDFQGCNFS
     EKNMYARDRR DGQSKEGSGR VAIYKASGII HSYTLECNYN TGRSVNSIPA ACHDNGRASP
     PPPPAFPSRY TVELFEQVGR AMAIAALDMA ECNPWPRIVL SEHSSLTNLR AWMLRHVRNS
     RGLTSAGNMG ASKKRGARTP PKSNNSLPVS CSENALSRVR SFSTGTSTGG SSSSQQNSPQ
     MKNSPSFPFH GSRTAGLPGL GSSTQKVSHR VLGPVREPRC SDRRRRQQPL NHRSTTSSLA
     PSPTLASSGP TSSRNMGSCL LPNSLSLSGS SCSFSSSGDK PEAVMVIGKS LLGAGARIPC
     IRTRLQARPR LGRSSPPTRR GMRGSSPTSP IPQTRESSEL EPGPHSATPG LPQAGPPRPR
     SAPAFSPISC TLSDSPSRIC YSRGLLNQCE VCFVPKSPPL TISPRV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025